Status:
COMPLETED
Post Marketing Surveillance (PMS) Study to Assess Safety and Efficacy of Micardis in Patients With Essential Hypertension
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Hypertension
Eligibility:
All Genders
Brief Summary
The objective of this PMS study was to monitor and assess the safety of Micardis tablets in patients with hypertension over a period of 6 years
Eligibility Criteria
Inclusion
- Male and female patients diagnosed with essential hypertension
- Patients without prior experience with Micardis tablet
Exclusion
- Known hypersensitivity to Micardis tablet
- Pregnancy or breastfeeding
- Biliary atresia
- Severe hepatic failure patients
- Severe renal failure patients
Key Trial Info
Start Date :
November 1 2000
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
13066 Patients enrolled
Trial Details
Trial ID
NCT02245464
Start Date
November 1 2000
Last Update
September 19 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.